Danaher Corp
DHRNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 21, 2026Score 12/3025% above fair value
$227.97−4.26 (-1.83%)
Close on Nov 2, 2026Market cap $160.26BP/E 40.5Yield –
Danaher Biotechnology — Reported GAAP Operating Margin by Year
Biotechnology — Reported GAAP Operating Margin (%)
Danaher Biotechnology — Reported GAAP Operating Margin: 25.6% in FY2025, up 0.7 pts from a year earlier.
Latest, FY2025
25.6%
Period ended Dec 31, 2025
Change on a year earlier
+0.7 pts
24.9% in FY2024
History
5 years
Since FY2021
Sources
3
Documents cited below
Where the FY2025 figure comes from
Source: Danaher IR — nongaap_2025Q4 ↗
Reported in Danaher Non-GAAP Reconciliations & Supplemental Data (8-K / IR PDF).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Biotechnology — Reported GAAP Operating Margin (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 25.6% | +0.7 pts | Danaher IR — nongaap_2025Q4 ↗ |
| FY2024 | Dec 31, 2024 | 24.9% | -1.7 pts | Danaher IR — nongaap_2025Q4 ↗ |
| FY2023 | Dec 31, 2023 | 26.6% | -7.7 pts | Danaher IR — nongaap_2024Q4 ↗ |
| FY2022 | Dec 31, 2022 | 34.3% | -1.6 pts | Danaher IR — nongaap_ex_veralto ↗ |
| FY2021 | Dec 31, 2021 | 35.9% | – | Danaher IR — nongaap_ex_veralto ↗ |
Cite this data
StockData. (2026). Danaher Biotechnology — Reported GAAP Operating Margin (%), annual FY2021–FY2025 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/gaap-op-margin-biotech
See every metric in the Danaher KPI table. Data updated Nov 2, 2026.